title: Diagnosis, laboratory aspects and management of acquired hemophilia A.
abstract: Acquired hemophilia A (AHA) is a rare autoimmune disease, characterized by severe, often life-threatening hemorrhages in patients without a prior history of bleeding disorder. It most frequently occurs in the elderly, and may be associated with other clinical conditions, such as cancer, autoimmune diseases, pregnancy or without a relevant cause. Diagnosis and correct therapy are crucial for the patient's outcome. Management of the disease consists of gaining immediate control of acute bleeding and the starting of an immunosuppressive therapy in order to eradicate the anti-factor VIII autoantibody. Factor VIII bypassing agents, such as prothrombin complex concentrates or recombinant activated factor VII, have proven effective in bleeding control, whereas the combined therapy of cyclophosphamide and corticosteroids seems to be, at present, the best immunosuppressive option. Other treatments including Rituximab, immunoadsorption or induction of immune tolerance are still experimental, and need to be validated through controlled clinical trials.
authors.affiliation: Servizio di Immunoematologia e Trasfusione, Centro Emostasi e Trombosi, AO Ospedale San Carlo Borromeo, Via Pio II, 3, 20153, Milan, Italy. vincenzo.toschi1@alice.it
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Toschi
authors.forename: Francesco
authors.initials: F
authors.lastname: Baudo
mesh_terms: D001327:Autoimmune Diseases / Q000175:diagnosis; D005169:Factor VIII / Q000032:analysis*; D006467:Hemophilia A / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans
chemical_list: D005169:Factor VIII
references.citation: Med Sci Monit. 2007 Apr;13(4):RA55-61
references.pmid: 17392659
references.citation: Thromb Haemost. 2006 Aug;96(2):119-25
references.pmid: 16894452
references.citation: Thromb Haemost. 1981 Jun 30;45(3):200-3
references.pmid: 6792737
references.citation: Clin Exp Rheumatol. 1996 Sep-Oct;14(5):559-60
references.pmid: 8913660
references.citation: Thromb Haemost. 2006 Jul;96(1):84-7
references.pmid: 16807656
references.citation: Clin Chim Acta. 2008 Sep;395(1-2):14-8
references.pmid: 18505682
references.citation: Thromb Haemost. 1995 Jan;73(1):1-5
references.pmid: 7740477
references.citation: Blood. 1995 Jul 15;86(2):797-804
references.pmid: 7606010
references.citation: Ann Hematol. 1997 Feb;74(2):89-93
references.pmid: 9063379
references.citation: J Thromb Haemost. 2007 May;5(5):893-900
references.pmid: 17461924
references.citation: Haemophilia. 2005 Sep;11(5):510-5
references.pmid: 16128896
references.citation: Haematologica. 2004 Jun;89(6):759-61
references.pmid: 15194550
references.citation: Haemophilia. 2007 Sep;13(5):451-61
references.pmid: 17880429
references.citation: Ann Intern Med. 1989 May 15;110(10):774-8
references.pmid: 2496636
references.citation: Am J Hematol. 1993 Aug;43(4):295-9
references.pmid: 8372811
references.citation: Rev Clin Exp Hematol. 2001 Dec;5(4):389-404; quiz following 431
references.pmid: 11844135
references.citation: Thromb Haemost. 1996 Jan;75(1):25-9
references.pmid: 8713775
references.citation: Thromb Haemost. 1995 Feb;73(2):247-51
references.pmid: 7792738
references.citation: Haematologica. 2009 Apr;94(4):566-75
references.pmid: 19336751
references.citation: Haemophilia. 2008 Sep;14(5):898-902
references.pmid: 18684126
references.citation: Blood. 2004 Jun 15;103(12):4424-8
references.pmid: 14996701
references.citation: Blood. 2005 Mar 15;105(6):2287-93
references.pmid: 15542586
references.citation: Haematologica. 2004 Jan;89(1):96-100
references.pmid: 14754611
references.citation: BJOG. 2003 Mar;110(3):311-4
references.pmid: 12628274
references.citation: Thromb Haemost. 2005 Apr;93(4):792-3
references.pmid: 15841330
references.citation: Haematologica. 2000 Oct;85(10 Suppl):57-61; discussion 61-3
references.pmid: 11187873
references.citation: Baillieres Clin Haematol. 1996 Jun;9(2):331-54
references.pmid: 8800509
references.citation: Br J Haematol. 2003 Apr;121(1):21-35
references.pmid: 12670328
references.citation: Blood. 2008 Jul 15;112(2):250-5
references.pmid: 18463353
references.citation: Haemophilia. 2001 Mar;7(2):164-9
references.pmid: 11260276
references.citation: Haematologica. 2000 Aug;85(8):895-6
references.pmid: 10942956
references.citation: Haemophilia. 2008 May;14(3):476-83
references.pmid: 18393980
references.citation: Crit Rev Oncol Hematol. 2008 Jun;66(3):194-9
references.pmid: 18243727
references.citation: Ann Intern Med. 1997 Aug 1;127(3):206-9
references.pmid: 9245226
references.citation: Br J Haematol. 1996 Dec;95(4):750-3
references.pmid: 8982056
references.citation: Haemophilia. 2004 Mar;10(2):169-73
references.pmid: 14962206
references.citation: Haematologica. 2000 Oct;85(10 Suppl):64-8
references.pmid: 11187874
references.citation: Haemophilia. 2001 Mar;7(2):160-3
references.pmid: 11260275
references.citation: Blood. 2007 Mar 1;109(5):1870-7
references.pmid: 17047148
references.citation: Br J Haematol. 2001 Jan;112(1):91-7
references.pmid: 11167789
references.citation: Thromb Haemost. 1993 Nov 15;70(5):753-7
references.pmid: 8128430